162 participants
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2027-04-12
- Completion:
- 2029-03-31
Conditions
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
Interventions
- PROCEDURE
- DRUG
- OTHER
No Results Yet